Literature DB >> 26218336

Simultaneous Characterization of Intravenous and Oral Pharmacokinetics of Lychnopholide in Rats by Transit Compartment Model.

Larissa Lachi-Silva1, Sherwin K B Sy2, Alexander Voelkner2, João Paulo Barreto de Sousa3, João Luis C Lopes3, Denise B Silva3, Norberto P Lopes3, Elza Kimura1, Hartmut Derendorf2, Andrea Diniz1.   

Abstract

The pharmacokinetic properties of a new molecular entity are important aspects in evaluating the viability of the compound as a pharmacological agent. The sesquiterpene lactone lychnopholide exhibits important biological activities. The objective of this study was to characterize the pharmacokinetics of lychnopholide after intravenous administration of 1.65 mg/kg (n = 5) and oral administration of 3.3 mg/kg (n = 3) lychnopholide in rats (0.2 ± 0.02 kg in weight) through nonlinear mixed effects modeling and non-compartmental pharmacokinetic analysis. A highly sensitive analytical method was used to quantify the plasma lychnopholide concentrations in rats. Plasma protein binding of this compound was over 99 % as determined by a filtration method. A two-compartment body model plus three transit compartments to characterize the absorption process best described the disposition of lychnopholide after both routes of administration. The oral bioavailability was approximately 68 %. The clearance was 0.131 l/min and intercompartmental clearance was 0.171 l/min; steady-state volume of distribution was 4.83 l. The mean transit time for the absorption process was 9.15 minutes. No flip-flop phenomenon was observed after oral administration. The pharmacokinetic properties are favorable for further development of lychnopholide as a potential oral pharmacological agent. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26218336     DOI: 10.1055/s-0035-1546214

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  4 in total

1.  Lychnopholide in Poly(d,l-Lactide)-Block-Polyethylene Glycol Nanocapsules Cures Infection with a Drug-Resistant Trypanosoma cruzi Strain at Acute and Chronic Phases.

Authors:  Renata Tupinambá Branquinho; Carlos Geraldo Campos de Mello; Maykon Tavares Oliveira; Levi Eduardo Soares Reis; Paula Mello de Abreu Vieira; Dênia Antunes Saúde-Guimarães; Vanessa Carla Furtado Mosqueira; Marta de Lana
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191

2.  Efficacy of Lychnopholide Polymeric Nanocapsules after Oral and Intravenous Administration in Murine Experimental Chagas Disease.

Authors:  Carlos Geraldo Campos de Mello; Renata Tupinambá Branquinho; Maykon Tavares Oliveira; Matheus Marques Milagre; Dênia Antunes Saúde-Guimarães; Vanessa Carla Furtado Mosqueira; Marta de Lana
Journal:  Antimicrob Agents Chemother       Date:  2016-08-22       Impact factor: 5.191

3.  Population Pharmacokinetic and Covariate Analysis of Apatinib, an Oral Tyrosine Kinase Inhibitor, in Healthy Volunteers and Patients with Solid Tumors.

Authors:  Mingming Yu; Zhiwei Gao; Xiaojian Dai; Hui Gong; Lianshan Zhang; Xiaoyan Chen; Da-Fang Zhong; Sherwin K B Sy
Journal:  Clin Pharmacokinet       Date:  2017-01       Impact factor: 6.447

4.  Increased Body Exposure to New Anti-Trypanosomal Through Nanoencapsulation.

Authors:  Renata Tupinambá Branquinho; Gwenaelle Pound-Lana; Matheus Marques Milagre; Dênia Antunes Saúde-Guimarães; José Mário Carneiro Vilela; Margareth Spangler Andrade; Marta de Lana; Vanessa Carla Furtado Mosqueira
Journal:  Sci Rep       Date:  2017-08-16       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.